UC study examines immunotherapy’s effect on COVID-19 outcomes

What are The CheckPoints movin’ and groovin’ to this summer?
Join the journal club with the best bops: We asked SITC’s 13-piece band of medical musicians for the top papers and songs of the summer

Physician-scientists by day, a funk-loving musical troupe by night. You may have seen The CheckPoints—a 13 member cover band with a three-piece brass section and Jim Allison on harmonica—movin’, groovin’, and gettin’ down as a mainstay closing act at ASCO, AACR, or the Society for Immunotherapy of Cancer annual meetings.

August 14, 2026

Vol.52 No.32

By Sara Willa Ernst and Paul Goldberg

In Brief

Stand Up To Cancer Nicolai Award will fund KRAS-targeted immunotherapy combination for pancreatic cancer

Stand Up To Cancer announced the recipients of the SU2C Nina Nicolai Pancreatic Cancer Innovation in Collaboration Award.

August 14, 2026

Vol.52 No.32

In Brief

Society for Immunotherapy of Cancer announces 2026 annual award recipients

The Society for Immunotherapy of Cancer announced the recipients of its 2026 Annual Awards, recognizing individuals whose exceptional leadership, scientific achievements and service have helped advance the field of cancer immunotherapy.

August 07, 2026

Vol.52 No.31

Clinical Trials & Tribulations

Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation

The recent retraction of the LungTIME-C01 randomized trial evaluating chrono-modulated immunotherapy in non-small cell lung cancer has ignited a vigorous debate regarding the promise of cancer chronotherapy.

July 31, 2026

Vol.52 No.30

By Zachary S. Buchwald and Michael C. Lowe

News Analysis

A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.
The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m.

On Feb. 2, Nature Medicine published the results of a large, randomized, prospective clinical trial in the nascent and some say, fringe, field of chrono-oncology—the study of how natural biological rhythms might impact cancer outcomes.

July 10, 2026

Vol.52 No.27

By Jacquelyn Cobb

As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded

Last week, Wafik El-Deiry, a cancer researcher at Brown University, showed up at a Senate hearing to talk about what he sees as dangers of the COVID-19 vaccine.

June 12, 2026

Vol.52 No.23

By Paul Goldberg

UC study examines immunotherapy’s effect on COVID-19 outcomes

YOU MAY BE INTERESTED IN

What are The CheckPoints movin’ and groovin’ to this summer?
Join the journal club with the best bops: We asked SITC’s 13-piece band of medical musicians for the top papers and songs of the summer

Stand Up To Cancer Nicolai Award will fund KRAS-targeted immunotherapy combination for pancreatic cancer

Society for Immunotherapy of Cancer announces 2026 annual award recipients

Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation

A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.
The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m.

As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded

Renew today!

Subscriber content

Never miss an issue!

Login

UC study examines immunotherapy’s effect on COVID-19 outcomes

YOU MAY BE INTERESTED IN

What are The CheckPoints movin’ and groovin’ to this summer?Join the journal club with the best bops: We asked SITC’s 13-piece band of medical musicians for the top papers and songs of the summer

Stand Up To Cancer Nicolai Award will fund KRAS-targeted immunotherapy combination for pancreatic cancer

Society for Immunotherapy of Cancer announces 2026 annual award recipients

Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation

A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m.

As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick labThe job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded

Never miss an issue!

Login

What are The CheckPoints movin’ and groovin’ to this summer?
Join the journal club with the best bops: We asked SITC’s 13-piece band of medical musicians for the top papers and songs of the summer

A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.
The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m.

As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded